Zhengye Biotechnology Holding (ZYBT) Loans and Notes Receivables (2023 - 2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Zhengye Biotechnology Holding (ZYBT) has disclosed Loans and Notes Receivables for 2 consecutive years, with $3.6 million as the latest value for Q4 2024.

• Quarterly Loans and Notes Receivables rose 10.5% to $3.6 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Dec 2024, up 10.5% year-over-year, with the annual reading at $3.5 million for FY2024, 6.73% up from the prior year.
• Loans and Notes Receivables for Q4 2024 was $3.6 million at Zhengye Biotechnology Holding, up from $3.2 million in the prior quarter.
• The five-year high for Loans and Notes Receivables was $3.6 million in Q4 2024, with the low at $3.2 million in Q4 2023.

Peer Comparison